Advertisement

Topics

Orexo AB Company Profile

16:37 EST 10th December 2018 | BioPortfolio

We start by matching unmet patient needs with the unrealized potential in many existing compounds. We create novel pharmaceuticals, at lower development cost and risk, with shorter time to market.
The right time for a great concept
What if it were possible to take good drugs with high commercial value and make them even better? Not just through minor reformulations or patent extensions, but by adding innovative properties that really benefit patients? This is precisely what a Swedish physician and his colleagues asked themselves in 1995 when they founded Orexo.
Since then, Orexo has become a progressive, fast-growing pharmaceutical company. We’re product-focused, not platform-driven, and we have a proven track record.
Our approach is to develop proprietary pharmaceuticals to address areas of unmet therapeutic need. We do this by using a stepwise synergy process: First we assess areas of need. Then we work to meet the need by combining existing substances with our proprietary drug delivery technologies and unique expertise in dry pharmaceutical formulations.

Location

P.O. Box 303
Uppsala
SE-751 05
Sweden

Contact

Phone: 46 (0)18 780 88 00
Fax: 46 (0)18 780 88 88
Email: info@orexo.se


News Articles [27 Associated News Articles listed on BioPortfolio]

Orexo (ORX) - Blue Skies

Edison Investment Research - Pharmaceutical & healthcare - Orexo: The growing US Zubsolv franchise continues to drive Orexo’s quarterly performance. Total Q3 revenue growth of c 30% puts Orexo i...

Orexo (ORX) - Orexo wins patent litigation appeal

Edison Investment Research - Pharmaceutical & healthcare - Orexo: Orexo’s appeal of the US District Court’s invalidation of the ‘330 patent, which had been anticipated for some month...

Orexo Wins Appeal Against Actavis on Zubsolv Patent in the US

UPPSALA, Sweden, Sept. 10, 2018 /PRNewswire/ -- Orexo AB (publ.) today announces that the US Court of Appeals for the Federal Circuit found Orexo's long term Zubsolv patent US 8,940,330 to be vali...

Orexo (ORX) - One of the best ever quarters

Edison Investment Research - Pharmaceutical & healthcare - Orexo: In a well-received set of quarterly results, Orexo continued to execute on Zubsolv in the US, which, for the second quarter running, c...

Orexo (ORX) - EU launch milestone achieved

Edison Investment Research - Pharmaceutical & healthcare - Orexo: Yesterday Orexo announced the launch of Zubsolv in the EU by its partner Mundipharma, triggering a €3m (c SEK30.6m) milestone pay...

Orexo Wins Appeal Against Teva Unit Over Generic of Zubsolv

NewsThe U.S. Court of Appeals for the Federal Circuit found Orexo's long term Zubsolv patent US 8,940,330 to be valid.Contributed Author: 

Orexo to Host a Capital Markets Day on Dec. 6 With the US President's Former Advisor as Keynote Speaker

INVITATION UPPSALA, Sweden, Nov. 8, 2018 /PRNewswire/ --Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, invites investors, analysts an...

Save the Date: Orexo to Host Capital Markets Day on Dec. 6 With the US President's Former Advisor as Key Note Speaker

UPPSALA, Sweden, Oct. 24, 2018 /PRNewswire/ -- Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the Company will h...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis

This is a phase II study in patients with seasonal allergic rhinitis (SAR) and will compare the effect versus placebo of two different oral doses of BLX-028914 in an allergen challenge mod...

Companies [1 Associated Companies listed on BioPortfolio]

Orexo AB

We start by matching unmet patient needs with the unrealized potential in many existing compounds. We create novel pharmaceuticals, at lower development cost and risk, with shorter time to market. The...

More Information about "Orexo AB" on BioPortfolio

We have published hundreds of Orexo AB news stories on BioPortfolio along with dozens of Orexo AB Clinical Trials and PubMed Articles about Orexo AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orexo AB Companies in our database. You can also find out about relevant Orexo AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record